Pharmaniaga incurs RM178.6mil net loss in fourth quarter


Pharmaniaga said the higher revenue was mainly attributable to stronger demand from the concession, non-concession and Indonesia businesses.

PETALING JAYA: Pharmaniaga Bhd slid into a net loss of RM178.6mil for the fourth quarter ended Dec 31,2019, from a net profit of RM4.4mil in the corresponding quarter in the preceding year.

For the quarter in review, the pharmaceutical company saw its revenue grow 20% to RM715.7mil from RM596.6mil.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , loss , fourth quarter , Indonesian , business , revenue ,

Next In Business News

Chile’s hot for investors
Don’t bend lending rules for power boom
Sarawak fine-tunes hydrogen ambition
A conflict that’s set to hurt margins
Stocks not doomed in stagflation
Staying rational in volatile times
Joe Holding swaps batteries for bites
Private-credit strain spreads�
AI rewrites Bollywood’s script
A strain on supply chains�

Others Also Read